Fred Baron update: Biogen caves in to human decency

October 16, 2008

Mesothelioma titan Fred Baron will receive the last chance drug he needs to fight back what is likely terminal multiple myeloma, despite Biogen’s initial reluctance to provide the drug for off label use even with FDA approval, immunity from suit, and the plea of senators, ex-presidents, and tort giants like Mark Lanier.

“Thanks to the persistence and hard work of so many friends, Fred has received Tysabri,” Baron’s wife, Lisa Blue, said in an e-mailed statement. “The Mayo Clinic working with the FDA found a legal basis for this use. We have every expectation of a positive result.” The whole story is here.

Advertisements